GeneSight, a Mason-based company specializing in mental health medication, expanded its wellness services in the community.
Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...
Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago. These figures are ...
Masimo Corp. (MASI) on Tuesday reported third-quarter earnings of $9.8 million. On a per-share basis, the Irvine, California-based company said it had ...
The tech giant also allegedly attempted to hire away key employees, including Cercacor’s former chief technology officer and ...
Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...